Ogden C, Carroll M, Curtin L et al.: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-55.
Zdrojewski T, Babińska Z, Bandosz P et al.: Association of increased blood preasure with overweight and obesity: estimated from representative surveys in Poland in 1997 and 2002 (NATPOL II, NATPOL III). Med Metabol 2002; 4 (supl.): 32.
Biela U, Pajk A, Kaczmarek-Chałas K i wsp.: Czstość wystpowania nadwagi i otyłości u kobiet i mżczyzn w wieku 20-74 lata. Wyniki programu WOBASZ. Kard Pol 2005; 63 (supl. 4): 51-54.
Drenick EJ, Bale GS, Seltzer F et al.: Excessive mortality and causes of death in morbidly obese men. JAMA 1980; 243: 443-45.
Meneghini L: Impact of bariatric surgery on type 2 diabetes. Cell Biochem Biophys 2007; 48: 97-102.
Colquitt J, Picot J, Loveman E et al.: Surgery for obesity. Cochrane Database Syst Rev 2009 Apr 15; (2): CD003641.
Strzelczyk J, Szymański D, Nowicki M et al.: Randomized clinical trial of postoperative hernia prophylaxis in open bariatric surgery. Br J Surg 2006; 93: 1347-50.
Avidor Y, Still C, Brunner M et al.: Primary care and subspecialty management of morbid obesity: referral patterns for bariatric surgery. Surg Obes Relat Dis 2007; 3: 392-407.
Nieben OG, Harboe H.: Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982; 1(8265): 198-99.
Żurawiński W, Sosada K, Jopek J i wsp.: Endoskopowe leczenie otyłości z zastosowaniem balonu dożołdkowego. Pol Przegl Chir 2010; 82: 754-61.
Pawlik M, Rydzewska G: Metody terapeutyczne leczenia otyłości z uwzgldnieniem zastosowania balonów dożołdkowych. Pol Merk Lek 2009; 26: 527-31
Świdnicka-Siergiejko A, Wróblewski E, Dbrowski A: Endoskopowe metody leczenia otyłości. Gastroenterol Praktyczna 2010; 2: 62-72.
Dumonceau JM: Evidence-based review od bioenterics intragastric balloon for weight loss. Obes Surg 2008; 18: 1611-17.
Dumonceau JM, François E, Hittelet A et al.: Single vs Repeated Treatment with the Intragastric Balloon: A 5-Year Weight Loss Study. Obes Surg 2010; 206: 692-97
Lopez-Nava G, Rubio MA, Prados S et al.: Bio-Enterics® Intragastric Balloon (BIB)®. Single Ambulatory Center Spanish Experience with 714 Consecutive Patients Treated with One or Two Consecutive Balloons. Obes Surg 2010 (w druku).
Angrisani L, Lorenzo M, Borrelli V et al.: Is Bariatric Surgery Necessary after Intragastric Balloon Treatment. Obes Surg 2006; 16: 1135-37.
Vilallonga R, Fort JM, Gonzalez O et al.: Management of patients with hernia or incisional hernia undergoing surgery for morbid obesity. J Obes 2011 (w druku).
Głowińska-Olszewska B, Urban M: Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. Metabolism 2007; 56: 799-805.
Itani KM, Jensen EH, Finn TS et al.: Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery. Surg Infect (Larchmt) 2008; 9: 131-37.
Lynch RJ, Ranney DN, Shijie C et al.: Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg 2009; 250: 1014-20.
Drapeau CM, D'Aniello C, Brafa A et al.: Surgical site infections in plastic surgery: an Italian multicenter study. J Surg Res 2007; 143: 393-79.
Mullen JT, Moorman DW, Davenport DL: The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009; 250: 166-72
Mathur AK, Ghaferi AA, Sell K et al.: Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy. J Gastrointest Surg 2010; 14: 849-57.
Nafiu OO, Kheterpal S, Moulding R et al.: The association of body mass index to postoperative outcomes in elderly vascular surgery patients: a reverse J-curve phenomenon. Anesth Analg 2011; 112: 23-29.
de Goederen-van der Meij S, Pierik RG, Oudkerk Pool M et al.: Six months of balloon treatment does not predict the success of gastric banding. Obes Surg 2007; 17: 88-94.
Genco A, Cipriano M, Materia A et al.: Laparoscopic sleeve gastrectomy versus intragastric balloon: a case-control study. Surg Endosc 2009; 23: 1849-53.
Milone L, Strong V, Gagner M: Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for superobese patients (BMI≥ 50). Obes Surg 2005; 15: 612-17.
De Waele B, Reynaert H, Urbain D et al.: Intragastric balloons for preoperative weight reduction. Obes Surg 2000; 10: 58-60.
Fernandes M, Atallah AN, Soares BG et al.: Intragastric balloon for obesity. Cochrane Database Syst Rev 2007 Jan 24; (1): CD004931.
Mathus-Vliegen EM: Intragastric balloon treatment for obesity: what does it really offer? Did Dis 2008; 26: 40-44.
Crea N, Pata G, Della Casa D et al.: Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg 2009; 19: 1084-88.
Mui WL, Ng EK, Tsung BY et al.: Impact on Obesity-Related Illnesses and Quality of Life Following Intragastric Balloon. Obes Surg 2010; 20: 1128-32.
Ganesh R, Rao AD, Baladas HG et al.: The Bioenteric® Intragastric Balloon (BIB®) as a treatment for obesity: poor results in Asian patients. Singapore Med J 2007; 48: 227-31
Cubattoli L, Barneschi C, Mastrocinque E et al.: Cardiac arrest after intragastric balloon insertion in a super-obese patient. Obes Surg 2009; 19: 253-56.
Konopko-Zubrzycka M, Baniukiewicz A, Wróblewski E et al.: The effect of intragastric balloon on plasma ghrelin, leptin, and adiponectin levels in patients with morbid obesity. J Clin Endocrinol Metab 2009; 94: 1644-49.
Comments (0)